Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05599672 · ClinicalTrials.gov registry record · NA
Co-Use of Opioid Medications and Alcohol Prevention Study
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT05599672: Completed NA study, sponsored by University of Utah.
NCT05599672 is a NA study that has completed, run by University of Utah. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05599672, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
Previous research, including that of this team, shows that a significant portion of those regularly using opioids-particularly filling opioids at community pharmacies-also are involved in the co-use of alcohol. This study proposes to adapt a previously developed intervention for opioid medication misuse; test its acceptability, feasibility, and preliminary efficacy; and identify barriers and facilitators to large-scale research and system-level implementation. Results of this study will directly inform a fully-powered subsequent multisite trial.
Primary Outcome
The investigators will use the Timeline Follow Back to assess alcohol use reductions. This measure is a calendar based assessment that captures a continuous number (counts) of days of substance use. This quantitative measure is both valid and reliable.
Interventions
- BEHAVIORAL Alcohol-targeted Brief Intervention-Medication Therapy Management
- BEHAVIORAL Standard medication counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2024-08-19 |
| Phase | NA |
What the finished NCT05599672 record still lists
NCT05599672 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Alcohol-targeted Brief Intervention-Medication Therapy Management is the first listed.
NCT05599672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05599672 about?
NCT05599672 is a clinical study titled "Co-Use of Opioid Medications and Alcohol Prevention Study". Previous research, including that of this team, shows that a significant portion of those regularly using opioids-particularly filling opioids at community pharmacies-also are involved in the co-use of alcohol. This study proposes to adapt a previously developed intervention for opioid medication mi...
What is the current status of trial NCT05599672?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2023-05-01. Estimated completion is 2024-08-19.
What interventions are being tested in trial NCT05599672?
The interventions under investigation include: Alcohol-targeted Brief Intervention-Medication Therapy Management (BEHAVIORAL), Standard medication counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05599672?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05599672's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI